1. Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials. Issue 17 (November 2015) Authors: Duffaud, F.; Sleijfer, S.; Litière, S.; Ray-Coquard, I.; Le Cesne, A.; Papai, Z.; Judson, I.; Schöffski, P.; Chawla, S.P.; Dewji, R.; Marreaud, S.; Verweij, J.; van der Graaf, W.T. Journal: European journal of cancer Issue: Volume 51:Issue 17(2015:Nov.) Page Start: 2615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗